Bio-Ker S.R.L.
Records under this name other than the patents Bio-Ker S.R.L. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 6 of 6 · Back to Bio-Ker S.R.L.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,580,733 | Site-specific monoconjugated insulinotropic GLP-1 peptides Lapsed on the fee record Ended Nov 12, 2025 · USPTO record | Lapsed on the fee record | Ended Nov 12, 2025 | USPTO record |
| US 7,410,775 | Method for making recombinant peptides or proteins using soluble endoproteases Lapsed on the fee record Ended Aug 12, 2020 · USPTO record | Lapsed on the fee record | Ended Aug 12, 2020 | USPTO record |
| US 7,241,609 | Soluble endoproteases for the in vitro processing of recombinant proteins Lapsed on the fee record Ended Jul 10, 2019 · USPTO record | Lapsed on the fee record | Ended Jul 10, 2019 | USPTO record |
| US 7,781,189 | Catalyzing transglycosylation using a recombinant host cell overexpressing uridine phosphorylase and purine nucleoside phosphorylase Formerly held Lapsed on the fee record Ended Aug 24, 2014 · USPTO record | Lapsed on the fee record | Ended Aug 24, 2014 | USPTO record |
| US 6,911,341 | Vectors, host cells, and methods for production of uridine phosphorylase and purine nucleoside phosphorylase Formerly held Lapsed on the fee record Ended Jun 28, 2013 · USPTO record | Lapsed on the fee record | Ended Jun 28, 2013 | USPTO record |
| US 7,354,759 | DNA vaccines expressing hypervariable VH-CDR3 idiotypic determinants Lapsed on the fee record Ended Apr 8, 2012 · USPTO record | Lapsed on the fee record | Ended Apr 8, 2012 | USPTO record |